← Back to headlines
Serina Therapeutics Reports GAAP EPS of -$1.91 and Revenue of $0.13M
Serina Therapeutics announced its latest financial results, reporting a GAAP Earnings Per Share (EPS) of -$1.91 and total revenue of $0.13 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippines Health Secretary Herbosa calls expired medicine complaints a 'demolition job'
just now
PhilHealth eyes accreditation of pediatric neurologists for autism care
just now
FG, Senator Unveil Hepatitis Intervention for Southern Kaduna Residents
just now
Chinese Company to Invest €100 Million in Bosnia and Herzegovina Healthcare
10m ago